Medical News

RSS

XBiotech reports interim results from Phase III study for anti-cancer agent Xilonix

XBiotech announced today interim results from its fast-tracked Phase III study being conducted in the US for its anti-cancer agent Xilonix.

2 Sep 2014

BioPhotas launches Celluma ELITE for sale to Aesthetic Physician Market

BioPhotas, Inc. today announced the launch of the Celluma ELITE for sale to the Aesthetic Physician Market. The LED therapy device is stand-mounted and able to be precisely positioned over an area of treatment via an articulating arm and a patented shape-taking light panel.

2 Sep 2014

Nomination signals new approach to drug abuse policy

The nomination of Michael Botticelli to head the Office of National Drug Control Policy symbolizes the shift toward dealing with drug use as a public health rather than as a criminal justice issue, writes The Washington Post. Reuters looks at how opioid abuse fears keep cancer patients from getting pain relief.

2 Sep 2014

BioLegend acquires shares of Covance Antibody Services

BioLegend, Inc. (BioLegend) acquired the shares of Covance Antibody Services Inc., a business unit of Covance, located in Dedham, Massachusetts, on August 29, 2014.

From BioLegend 2 Sep 2014

Amgen seeks EMA approval for marketing talimogene laherparepvec

Amgen today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) via the centralized procedure for talimogene laherparepvec seeking approval for the treatment of adults with melanoma that is regionally or distantly metastatic.

2 Sep 2014

MEI Pharma completes patient enrollment in Pracinostat Phase II trial for treatment of MDS

MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has completed enrollment in a randomized Phase II clinical trial of its lead investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 or high-risk myelodysplastic syndrome (MDS).

2 Sep 2014

Travel time to breast imaging services in United States varies dramatically by modality

Mammography, ultrasound, and MRI - or a combination of these examinations - are critical in detecting, diagnosing, and characterizing the extent of breast cancer.

2 Sep 2014

VentiRx's motolimod receives FDA Fast Track designation for ovarian cancer treatment

VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.

2 Sep 2014

Coffee increases risk of prediabetes in young adults with hypertension

Coffee increases the risk of prediabetes in young adults with hypertension who are slow caffeine metabolisers, according to results from the HARVEST study presented at ESC Congress today by Dr Lucio Mos from Italy. People who drank more than three cups of coffee per day doubled their risk of prediabetes.

2 Sep 2014

Amida launches Blue Button-branded software component, Data Reconciliation Engine

Amida is pleased to announce the second release of its Data Reconciliation Engine (DRE). The DRE is a Blue Button-branded software component that supports the aims of the Blue Button Initiative, a nationwide public-private effort that enables patients and consumers to gain easy access to their own health information.

2 Sep 2014

Ampio updates phase III, multicenter, double-blind STEP study of Ampion for knee osteoarthritis

Ampio Pharmaceuticals, Inc. today announced an update on the phase III, multicenter, double-blind STEP study of Ampion™ for osteoarthritis of the knee.

2 Sep 2014

Synthetic announces positive results from final preclinical toxicology study of SYN-004

Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today positive results from its final preclinical toxicology study of SYN-004.

2 Sep 2014

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today promising preliminary results from a preclinical study with its ricin toxin vaccine RiVax™, in a non-human primate (NHP) lethal aerosol exposure model.

2 Sep 2014

Concordia's subsidiary signs collaboration deal with Orphan Canada for PHOTOFRIN

Concordia Healthcare Corp., a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, today announced that its subsidiary, Pinnacle Biologics, Inc., a biopharmaceutical research and development company specializing in rare diseases, has signed a collaboration agreement for PHOTOFRIN® with Orphan Canada, a Toronto-based specialty pharmaceutical company that in‐licenses therapies for rare disorders and specialty medicines within Canada.

2 Sep 2014

Cepheid releases Xpert Flu/RSV XC for accurate determination of Flu A, Flu B and RSV infection

Cepheid announced today the release of Xpert® Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination of Flu A, Flu B, and differentiation of RSV infection.

2 Sep 2014

BIOREM announces three new orders totalling $2.1 million

BIOREM Inc. today announced three new orders totalling $2.1 million. The orders consist of three large odour control systems for waste water treatment plants in Canada.

2 Sep 2014

First Edition: September 2, 2014

Today's early morning highlights from the major news organizations, including an analysis of care at small military hospitals and a look at the $8 billion in health law taxes that come due Sept. 30.

2 Sep 2014

Farmer Boys launches 14th annual fundraiser to benefit LLUCH

Farmer Boys announced today the launch of its 14th annual fundraiser benefitting the Loma Linda University Children's Hospital-LLUCH. The campaign will take place at participating Farmer Boys locations during the month of September.

2 Sep 2014

Redspin issues IT security advisory for senior executives in healthcare industry

Redspin, Inc., a leading provider of HIPAA security risk assessments and penetration testing services, today released an IT security advisory specifically for senior executives in the healthcare industry.

2 Sep 2014

Neuropsychologist sees increase in ADHD diagnoses

Since 2007, there has been a 16 percent increase in ADHD diagnoses in the United States. While this may alarm some parents, Kids In The House experts explain what this increase really means and how parents can help children who have been diagnosed with ADHD.

2 Sep 2014

Medical News

XBiotech reports interim results from Phase III study for anti-cancer agent Xilonix

BioPhotas launches Celluma ELITE for sale to Aesthetic Physician Market

Nomination signals new approach to drug abuse policy

BioLegend acquires shares of Covance Antibody Services

Amgen seeks EMA approval for marketing talimogene laherparepvec

MEI Pharma completes patient enrollment in Pracinostat Phase II trial for treatment of MDS

Travel time to breast imaging services in United States varies dramatically by modality

VentiRx's motolimod receives FDA Fast Track designation for ovarian cancer treatment

Coffee increases risk of prediabetes in young adults with hypertension

Amida launches Blue Button-branded software component, Data Reconciliation Engine

Ampio updates phase III, multicenter, double-blind STEP study of Ampion for knee osteoarthritis

Synthetic announces positive results from final preclinical toxicology study of SYN-004

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Concordia's subsidiary signs collaboration deal with Orphan Canada for PHOTOFRIN

Cepheid releases Xpert Flu/RSV XC for accurate determination of Flu A, Flu B and RSV infection

BIOREM announces three new orders totalling $2.1 million

First Edition: September 2, 2014

Farmer Boys launches 14th annual fundraiser to benefit LLUCH

Redspin issues IT security advisory for senior executives in healthcare industry

Neuropsychologist sees increase in ADHD diagnoses

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News